---
category: trading
circular_id: 27180878f9e8018a
date: '2025-09-09'
description: Amanta Healthcare Limited will be transferred from trade for trade segment
  to rolling segment effective September 23, 2025.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML70096.pdf
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Segment transfer affects trading mechanics for AMANTA stock, improving
  liquidity by moving from restricted to normal trading
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML70096.pdf
processing:
  attempts: 1
  content_hash: fb131023c130fbda
  processed_at: '2025-09-09T12:57:13.099132'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-09-09T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML70096.pdf
severity: medium
source: nse
stocks:
- AMANTA
tags:
- ipo
- listing
- rolling-segment
- segment-transfer
- trade-for-trade
title: Trade for Trade - Amanta Healthcare Limited
---

## Summary

Amanta Healthcare Limited will be transferred from the trade for trade segment (series: BE) to the rolling segment (series: EQ) effective September 23, 2025, following SEBI guidelines for IPO securities.

## Key Points

- Transfer from trade for trade segment (BE series) to rolling segment (EQ series)
- Change effective from September 23, 2025
- Follows previous exchange circular NSE/CML/70061 dated September 05, 2025
- Complies with SEBI circular CIR/MRD/DP/02/2012 dated January 20, 2012

## Regulatory Changes

The security will move from restricted trading (trade for trade) where each transaction requires individual settlement to normal rolling settlement allowing T+1 settlement cycle.

## Compliance Requirements

Members must be aware of the segment change and adjust their trading systems accordingly for the new series designation.

## Important Dates

- **September 23, 2025**: Effective date for segment transfer

## Impact Assessment

This change will improve liquidity for AMANTA stock by allowing normal trading mechanisms instead of the restrictive trade-for-trade settlement, making it more accessible to retail and institutional investors.